PRDM9 and cancer: PRDM9, a lysine methyltransferase that catalyzes methylation at the H3K4 mark, has been identified as an oncogene with broad involvement in multiple cancers including breast cancer, liver cancer, and head and neck squamous cell carcinoma [20].